• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

桦木酸通过 YY1/FAS 信号通路改善非酒精性脂肪性肝病。

Betulinic acid improves nonalcoholic fatty liver disease through YY1/FAS signaling pathway.

机构信息

Department of Endocrinology and Metabolism, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai National Clinical Research Center for metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.

出版信息

FASEB J. 2020 Sep;34(9):13033-13048. doi: 10.1096/fj.202000546R. Epub 2020 Aug 10.

DOI:10.1096/fj.202000546R
PMID:32777136
Abstract

The increasing prevalence of nonalcoholic fatty liver disease (NAFLD) worldwide indicates the urgent need to develop novel and effective treatment strategies. Betulinic acid (BA), a naturally occurring plant-derived pentacyclic triterpenoid, has an outstanding effect in improving metabolism. However, the pharmacological action and mechanism of BA in NAFLD remain unclear. Here, we show that BA-treated high-fat diet mice and methionine-choline deficient diet-fed mice are resistant to hepatic steatosis when compared with vehicle-treated mice. BA alleviates fatty acid synthesis, fibrosis, and inflammation and promotes fatty acid oxidation. Meanwhile, fatty acid synthase (FAS) expression and activity are markedly inhibited with BA treatment both in vitro and in vivo. Moreover, BA inhibits FAS expression through transcriptional suppression of Yin Yang 1 (YY1), leading to retard hepatocytes triglyceride accumulation. Collectively, BA protects hepatocytes from abnormal lipid deposition in NAFLD through YY1/FAS pathway. Our findings establish a novel role of BA in representing a possible therapeutic strategy to reverse NAFLD.

摘要

非酒精性脂肪性肝病(NAFLD)在全球范围内的患病率不断上升,表明迫切需要开发新的有效治疗策略。白桦脂酸(BA)是一种天然存在的植物衍生五环三萜,在改善代谢方面具有出色的效果。然而,BA 在 NAFLD 中的药理作用和机制尚不清楚。在这里,我们发现与载体处理的小鼠相比,BA 处理的高脂肪饮食小鼠和蛋氨酸-胆碱缺乏饮食喂养的小鼠对肝脂肪变性具有抗性。BA 可减轻脂肪酸合成、纤维化和炎症,并促进脂肪酸氧化。同时,BA 在体外和体内均显著抑制脂肪酸合酶(FAS)的表达和活性。此外,BA 通过转录抑制 Yin Yang 1(YY1)抑制 FAS 的表达,导致肝细胞甘油三酯积累减少。总之,BA 通过 YY1/FAS 通路保护肝细胞免受 NAFLD 中异常脂质沉积的影响。我们的研究结果确立了 BA 在代表一种可能的治疗策略以逆转 NAFLD 方面的新作用。

相似文献

1
Betulinic acid improves nonalcoholic fatty liver disease through YY1/FAS signaling pathway.桦木酸通过 YY1/FAS 信号通路改善非酒精性脂肪性肝病。
FASEB J. 2020 Sep;34(9):13033-13048. doi: 10.1096/fj.202000546R. Epub 2020 Aug 10.
2
Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway.桦木酸通过抑制 AMPK-mTOR-SREBP 信号通路来减轻非酒精性脂肪肝。
Biochem Pharmacol. 2013 May 1;85(9):1330-40. doi: 10.1016/j.bcp.2013.02.007. Epub 2013 Feb 19.
3
Betulinic acid alleviates endoplasmic reticulum stress-mediated nonalcoholic fatty liver disease through activation of farnesoid X receptors in mice.桦木酸通过激活法尼醇 X 受体减轻内质网应激介导的小鼠非酒精性脂肪性肝病。
Br J Pharmacol. 2019 Apr;176(7):847-863. doi: 10.1111/bph.14570. Epub 2019 Mar 18.
4
Betulinic acid inhibits high-fat diet-induced obesity and improves energy balance by activating AMPK.桦木酸通过激活 AMPK 抑制高脂肪饮食诱导的肥胖并改善能量平衡。
Nutr Metab Cardiovasc Dis. 2019 Apr;29(4):409-420. doi: 10.1016/j.numecd.2018.12.001. Epub 2019 Jan 8.
5
MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.微小RNA-122通过阴阳1抑制脂滴形成和肝脏甘油三酯蓄积。
Cell Physiol Biochem. 2017;44(4):1651-1664. doi: 10.1159/000485765. Epub 2017 Dec 6.
6
Jujuboside A through YY1/CYP2E1 signaling alleviated type 2 diabetes-associated fatty liver disease by ameliorating hepatic lipid accumulation, inflammation, and oxidative stress.酸枣仁皂苷 A 通过 YY1/CYP2E1 信号通路减轻 2 型糖尿病相关脂肪性肝病,改善肝脏脂质蓄积、炎症和氧化应激。
Chem Biol Interact. 2024 Sep 1;400:111157. doi: 10.1016/j.cbi.2024.111157. Epub 2024 Jul 24.
7
Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.漆黄素通过调节高脂肪饮食诱导的肥胖小鼠中的Sirt1/AMPK和脂肪酸β-氧化信号通路来预防肝脂肪变性。
Cell Physiol Biochem. 2018;49(5):1870-1884. doi: 10.1159/000493650. Epub 2018 Sep 20.
8
MiR-192-5p Ameliorates Hepatic Lipid Metabolism in Non-Alcoholic Fatty Liver Disease by Targeting .miR-192-5p 通过靶向. 改善非酒精性脂肪性肝病中的肝脂代谢。
Biomolecules. 2023 Dec 26;14(1):34. doi: 10.3390/biom14010034.
9
Prenatal dexamethasone exposure induces nonalcoholic fatty liver disease in male rat offspring via the miR-122/YY1/ACE2-MAS1 pathway.产前地塞米松暴露通过 miR-122/YY1/ACE2-MAS1 通路诱导雄性大鼠子代非酒精性脂肪性肝病。
Biochem Pharmacol. 2021 Mar;185:114420. doi: 10.1016/j.bcp.2021.114420. Epub 2021 Jan 16.
10
Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.樟芝及其复合成分去氢表雄酮酸通过上调 ALDH2 活性来减轻非酒精性脂肪肝疾病。
J Ethnopharmacol. 2022 Jun 28;292:115146. doi: 10.1016/j.jep.2022.115146. Epub 2022 Mar 16.

引用本文的文献

1
Ethanol extract of seeds alleviates HGHFD/STZ-induced nonalcoholic fatty liver disease in diabetic rats by modulating oxidative stress, inflammation, and lipid accumulation.种子的乙醇提取物通过调节氧化应激、炎症和脂质积累,减轻了高糖高脂饲料/链脲佐菌素诱导的糖尿病大鼠非酒精性脂肪性肝病。
Iran J Basic Med Sci. 2025;28(5):662-670. doi: 10.22038/ijbms.2025.82786.17889.
2
The Active Components of Traditional Chinese Medicines Regulate the Multi-Target Signaling Pathways of Metabolic Dysfunction-Associated Fatty Liver Disease.中药活性成分调控代谢功能障碍相关脂肪性肝病的多靶点信号通路
Drug Des Devel Ther. 2025 Apr 9;19:2693-2715. doi: 10.2147/DDDT.S514498. eCollection 2025.
3
Drug Advances in NAFLD: Individual and Combination Treatment Strategies of Natural Products and Small-Synthetic-Molecule Drugs.
非酒精性脂肪性肝病的药物进展:天然产物与小分子合成药物的个体化及联合治疗策略
Biomolecules. 2025 Jan 17;15(1):140. doi: 10.3390/biom15010140.
4
Genome-Wide Profiling of H3K27ac Identifies TDO2 as a Pivotal Therapeutic Target in Metabolic Associated Steatohepatitis Liver Disease.H3K27ac的全基因组分析确定TDO2是代谢相关脂肪性肝炎肝病的关键治疗靶点。
Adv Sci (Weinh). 2024 Dec;11(45):e2404224. doi: 10.1002/advs.202404224. Epub 2024 Oct 4.
5
Mechanism of Metabolic Dysfunction-associated Steatotic Liver Disease: Important role of lipid metabolism.代谢功能障碍相关脂肪性肝病的发病机制:脂质代谢的重要作用。
J Clin Transl Hepatol. 2024 Sep 28;12(9):815-826. doi: 10.14218/JCTH.2024.00019. Epub 2024 Sep 3.
6
Host cells reprogram lipid droplet synthesis through YY1 to resist PRRSV infection.宿主细胞通过 YY1 重新编程脂滴合成以抵抗 PRRSV 感染。
mBio. 2024 Aug 14;15(8):e0154924. doi: 10.1128/mbio.01549-24. Epub 2024 Jul 2.
7
YY1 Lactylation Aggravates Autoimmune Uveitis by Enhancing Microglial Functions via Inflammatory Genes.YY1 乳酰化通过炎症基因增强小胶质细胞功能加重自身免疫性葡萄膜炎。
Adv Sci (Weinh). 2024 May;11(19):e2308031. doi: 10.1002/advs.202308031. Epub 2024 Mar 17.
8
MiR-192-5p Ameliorates Hepatic Lipid Metabolism in Non-Alcoholic Fatty Liver Disease by Targeting .miR-192-5p 通过靶向. 改善非酒精性脂肪性肝病中的肝脂代谢。
Biomolecules. 2023 Dec 26;14(1):34. doi: 10.3390/biom14010034.
9
The Different Mechanisms of Lipid Accumulation in Hepatocytes Induced by Oleic Acid/Palmitic Acid and High-Fat Diet.油酸/软脂酸和高脂饮食诱导的肝细胞脂质蓄积的不同机制。
Molecules. 2023 Sep 20;28(18):6714. doi: 10.3390/molecules28186714.
10
Physiological and pathological roles of lipogenesis.脂生成的生理和病理作用。
Nat Metab. 2023 May;5(5):735-759. doi: 10.1038/s42255-023-00786-y. Epub 2023 May 4.